Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists

Yamin Shen, Chand Sultana, Moshe Arditi, Kwang Sik Kim, Vijay K. Kalra

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

The trafficking of monocytes across the endothelial lining of the blood vessel increases in response to bacterial infection at sites of inflammation. However, the molecular events involved in the diapedesis of monocytes in response to endotoxin are not completely understood. Our studies revealed that signaling by lipopolysaccharide (LPS) in human umbilical vein endothelial cells (HUVEC) resulted in a threefold increase in the transendothelial migration of monocyte-like HL-60 cells and a sevenfold increase in the phosphorylation of platelet endothelial cell adhesion molecule-1 (PECAM-1). The transmigration induced by LPS was inhibited by an antibody to PECAM-1. Both the phosphorylation of PECAM-1 and transendothelial migration of monocytes were inhibited by a platelet-activating factor (PAF) receptor antagonist, indicating the autocrine effect of PAF in these events. Treatment of HUVEC with LPS caused a fourfold increase in PAF receptor mRNA expression that was completely blocked by the PAF receptor antagonist. We conclude that PAF, generated by HUVEC in response to LPS or gram-negative bacterial infection, acts in an autocrine manner, causing PECAM-1 phosphorylation and thus the transendothelial migration of monocytes.

Original languageEnglish (US)
Pages (from-to)E479-E486
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume275
Issue number3 38-3
DOIs
StatePublished - Sep 1998
Externally publishedYes

Keywords

  • Diapedesis
  • Endothelial cells
  • Lipopolysaccharide
  • Platelet endothelial cell adhesion molecule-1
  • Platelet-activating factor
  • Transendothelial migration

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists'. Together they form a unique fingerprint.

Cite this